1. A prospective, multicenter, open-label, clinical trial design to evaluate the safety and efficacy of 90Y resin microspheres for treatment of unresectable hepatocellular carcinoma (HCC): DOORwaY90. (2021) Authors: Mahvash, A.; Chartier, S.; Turco, M.; Habib, P.; Griffith, S.; Brown, S.; Kappadath, S.C. Journal: HPB Issue: Volume 23(2021)Supplement 2 Page Start: S545 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗